BROOKWOOD BAPTIST HEALTH SERVICES acquired by ORLANDO HEALTH

Montefiore Investment acquired a majority stake in Demenego from Vam Investments. This secondary LBO follows a highly successful four-year period of ownership by the seller, during which the company more than doubled its revenue and expanded its retail network from 15 to 39 stores. The new partnership is designed to build on this solid foundation, with a strategic focus on further transforming the eyewear specialist into a national leader through innovation and omnichannel development. The investment strategy emphasizes continued significant investment in digitalization, customization technology, and the expansion of the "Demenego Labs" concept

Qualium Investissement is acquiring a 25% minority stake in IMPC from its associate radiologists. This primary LBO transaction follows a strategic period of reflection during which the founding doctors chose to maintain operational and capital control of their group rather than pursuing a majority sale. The operation is designed to provide the necessary capital to fund a targeted external growth strategy, particularly in the Paris region, while offering a medical-led alternative to the broader consolidation of the imaging market

L-GAM, CAPZA, IDIA Capital Investissement, and Bpifrance are acquiring a minority stake in PSV Group from its associate physicians. The transaction allows for the entry of a consortium of minority financial partners while ensuring that the associate doctors, who remain majority shareholders, retain full operational and strategic control of the group. This strategic partnership is designed to provide the financial resources and complementary expertise required to support an ambitious new development phase

Integral Diagnostics acquired 100% of Capitol Health via a Scheme of Arrangement. The transaction was approved by the ACCC after initial concerns, creating a highly synergistic group. The merger consolidates the fragmented Australian radiology market and provides the combined "MergeCo" with significant scale to invest in teleradiology (IDXt) and advanced AI diagnostic technologies.

Ardian's acquisition of Sagard's majority stake in Healthy Group, the parent company of Aprium Pharmacie, marks the end of a seven-year investment cycle characterized by the institutionalization of the platform and sustained organic growth of over 18% per annum between 2019 and 2023. This exit occurs as the French market for pharmacy groups is consolidating, with large urban pharmacies seeking to leverage dense central structures to optimize their transition to health service hubs. By partnering with Ardian's Growth team, Healthy Group's management, led by Emmanuel Schoffler, who is reinvesting significantly in the transaction, aims to execute a roadmap focused on densifying the national network through organic growth, enhancing omnichannel digital tools, and expanding the range of private-label products

X-Ray Phocea, a leading medical imaging group in Southern France, has secured a strategic minority investment from Essling Expansion, alongside Bpifrance and SOFIPACA. Despite this new capital entry, the majority of the group�s shareholding remains in the hands of its 20 associate radiologists, preserving a practitioner-led management model.

Andera Acto is providing minority financing to Imagerie Cardinet to support its next phase of expansion. The transaction is structured to allow the associate radiologists to maintain a massive majority, representing approximately 95% of the capital. This strategic funding provides the group with a development envelope of nearly EUR100 million to finance external growth. The investment strategy aims to reinforce the group's presence in the Paris region and initiate its expansion on a national scale, with several new centers expected to join by the end of the year

EQT, through its BPEA Fund VIII, agreed to acquire VetPartners from National Veterinary Associates (NVA), a portfolio company of JAB Holding. The transaction represents a major entry for EQT into the ANZ veterinary services market, following its extensive track record with IVC Evidensia in Europe. The strategic objective is to consolidate VetPartners' leadership position through significant capital investment in digital tools, advanced diagnostic equipment, and recruitment initiatives. The deal was finalized through a fast-tracked auction process where EQT was selected as the preferred bidder over rival private equity firms

Following a five-month bidding process, Bain Capital has entered into a definitive Scheme Implementation Agreement to acquire 100% of the share capital of Australian aged care operator Estia Health Limited. The public-to-private transaction is structured under a board-endorsed scheme of arrangement that permits the target to distribute fully franked dividends to eligible shareholders prior to the transaction's close. For the acquirer Bain Capital, the transaction expands its dedicated healthcare portfolio, leveraging a global platform that encompasses over 175 platform investments in the medical and care sectors

Quadrivio Group has acquired a majority stake in The Private Clinic from BlueGem Capital Partners to serve as a platform for its "Silver Economy" strategy. The industrial logic is anchored in the "healthy longevity" megatrend: as the population ages, demand for aesthetic and wellness treatments among the affluent over-50s is booming. The transaction was structured as a simultaneous "Buy-and-Build" play, as TPC acquired four smaller clinics specializing in cosmetic medicine at closing to immediately scale its footprint